Literature DB >> 27984128

DNA damage response in nephrotoxic and ischemic kidney injury.

Mingjuan Yan1, Chengyuan Tang1, Zhengwei Ma2, Shuang Huang3, Zheng Dong4.   

Abstract

DNA damage activates specific cell signaling cascades for DNA repair, cell cycle arrest, senescence, and/or cell death. Recent studies have demonstrated DNA damage response (DDR) in experimental models of acute kidney injury (AKI). In cisplatin-induced AKI or nephrotoxicity, the DDR pathway of ATR/Chk2/p53 is activated and contributes to renal tubular cell apoptosis. In ischemic AKI, DDR seems more complex and involves at least the ataxia telangiectasia mutated (ATM), a member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family, and p53; however, while ATM may promote DNA repair, p53 may trigger cell death. Targeting DDR for kidney protection in AKI therefore relies on a thorough elucidation of the DDR pathways in various forms of AKI. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Cisplatin; DNA damage response; Renal ischemia/reperfusion

Mesh:

Substances:

Year:  2016        PMID: 27984128      PMCID: PMC5362306          DOI: 10.1016/j.taap.2016.10.022

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  60 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  c-Abl stabilizes p73 by a phosphorylation-augmented interaction.

Authors:  Kelvin K C Tsai; Zhi-Min Yuan
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 3.  Death by design: apoptosis, necrosis and autophagy.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Curr Opin Cell Biol       Date:  2004-12       Impact factor: 8.382

Review 4.  Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

Authors:  D Lebwohl; R Canetta
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

Review 5.  Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.

Authors:  Neife Aparecida Guinaim dos Santos; Maria Augusta Carvalho Rodrigues; Nadia Maria Martins; Antonio Cardozo dos Santos
Journal:  Arch Toxicol       Date:  2012-03-01       Impact factor: 5.153

Review 6.  Maladaptive proximal tubule repair: cell cycle arrest.

Authors:  Joseph V Bonventre
Journal:  Nephron Clin Pract       Date:  2014-09-24

7.  Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.

Authors:  Giuliano Ciarimboli; Dirk Deuster; Arne Knief; Michael Sperling; Michael Holtkamp; Bayram Edemir; Hermann Pavenstädt; Claudia Lanvers-Kaminsky; Antoinette am Zehnhoff-Dinnesen; Alfred H Schinkel; Hermann Koepsell; Heribert Jürgens; Eberhard Schlatter
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

8.  ATM engages the TSC2/mTORC1 signaling node to regulate autophagy.

Authors:  Angela Alexander; Jinhee Kim; Cheryl L Walker
Journal:  Autophagy       Date:  2010-07-01       Impact factor: 16.016

Review 9.  Cellular processing of platinum anticancer drugs.

Authors:  Dong Wang; Stephen J Lippard
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

Review 10.  Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

Authors:  N Pabla; Z Dong
Journal:  Kidney Int       Date:  2008-02-13       Impact factor: 10.612

View more
  19 in total

1.  FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury.

Authors:  Fanghua Li; Zhiwen Liu; Chengyuan Tang; Juan Cai; Zheng Dong
Journal:  FASEB J       Date:  2018-01-22       Impact factor: 5.191

Review 2.  Acute kidney injury: emerging pharmacotherapies in current clinical trials.

Authors:  Stefanie Woolridge Benoit; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2017-06-10       Impact factor: 3.714

3.  2-Mercaptoethanol protects against DNA double-strand breaks after kidney ischemia and reperfusion injury through GPX4 upregulation.

Authors:  Daeun Moon; Babu J Padanilam; Hee-Seong Jang; Jinu Kim
Journal:  Pharmacol Rep       Date:  2022-08-22       Impact factor: 3.919

Review 4.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

Review 5.  Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury.

Authors:  Mingjuan Yan; Shaoqun Shu; Chunyuan Guo; Chengyuan Tang; Zheng Dong
Journal:  Ann Med       Date:  2018-07-11       Impact factor: 4.709

Review 6.  Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.

Authors:  Sara J Holditch; Carolyn N Brown; Andrew M Lombardi; Khoa N Nguyen; Charles L Edelstein
Journal:  Int J Mol Sci       Date:  2019-06-20       Impact factor: 5.923

7.  Melittin Inducing the Apoptosis of Renal Tubule Epithelial Cells through Upregulation of Bax/Bcl-2 Expression and Activation of TNF-α Signaling Pathway.

Authors:  Ying Shu; Yingying Yang; Yuliang Zhao; Liang Ma; Ping Fu; Tiantian Wei; Ling Zhang
Journal:  Biomed Res Int       Date:  2019-05-29       Impact factor: 3.411

8.  Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.

Authors:  Jing Liu; Man J Livingston; Guie Dong; Chengyuan Tang; Yunchao Su; Guangyu Wu; Xiao-Ming Yin; Zheng Dong
Journal:  Cell Death Dis       Date:  2018-02-23       Impact factor: 8.469

Review 9.  Epithelial Cell Cycle Behaviour in the Injured Kidney.

Authors:  Lies Moonen; Patrick C D'Haese; Benjamin A Vervaet
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

10.  Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway.

Authors:  Qing-Bo Lu; Qiong Du; Hui-Ping Wang; Zi-Han Tang; Yuan-Ben Wang; Hai-Jian Sun
Journal:  Redox Biol       Date:  2019-12-20       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.